Login / Signup

The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database.

Hao PengLei ChenYu-Pei ChenWen-Fei LiLing-Long TangAi-Hua LinYing SunJun Ma
Published in: PloS one (2018)
The role of plasma EBV DNA in clinical trials is underestimated, and high-level randomized clinical trials should be performed for patients with metastatic/recurrent disease.
Keyphrases
  • clinical trial
  • current status
  • phase ii
  • epstein barr virus
  • double blind
  • circulating tumor
  • cell free
  • single molecule
  • study protocol
  • phase iii
  • emergency department
  • adverse drug